POMICELL

AI-based Personalized Disease Models

Health Tech & Life Sciences
Non Active, Jun 2024 ceased to operate
Pre-Seed Jerusalem Founded 2016
LinkedIn
Total raised
$4.0M
Last: Pre-Seed 2017-01
Stage
Pre-Seed
Founded
2016
Headcount
5
HQ
Jerusalem
Sector
Health Tech & Life Sciences

About

Pomicell is the developer of POMI, a revolutionary AI SaaS solution that enables researchers in the biomedical field to enhance R&D processes with a quick, easy, three-click AI model creator.

The core AI-based capabilities offered by Pomicell’s platform include automatic disease treatment, big data modeling, automatic mechanism of action, hypothesis creation from literature, and a medical record-enhanced mechanism of action deciphering.

The company’s mission is to provide advanced digital tools aimed at enhancing personalized medicine by helping physicians quickly accelerate research and better understand their patients.

Funding history · 2 rounds · $4.0M total

2017-01
Pre-Seed $500K
Date unknown
Seed $1.5M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
Artificial IntelligenceMachine LearningNatural Language Processing
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 Patents

Tags

machine-learningdata-analyticsnatural-language-processingpersonalizationlaboratoriesacademiabig-data-analyticsartificial-intelligencedigital-healthcaremedical-technologiesdermatologypharma-companiescancerdecision-supportsoftware-platform